August J. Moretti - 21 Dec 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role: Chief Financial Officer
Signature: /s/ August J. Moretti
Issuer symbol: FDMT
Transactions as of: 21 Dec 2022
Net transactions value: +$28,230
Form type: 4
Filing time: 22 Dec 2022, 17:51:08 UTC
Previous filing: 06 Sep 2022
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FDMT	Common Stock	Options Exercise	$28,230	+3,000	+83%	$9.41	6,595	21 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FDMT	Stock Option (Right to Buy)	Options Exercise	$0	-3,000	-1.3%	$0.000000	220,060	21 Dec 2022	Common Stock	3,000	$9.41	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
F2	25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Content

Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.

25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.